Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Palliative Care
•
Critical Care
•
Hospital Medicine
Do you prefer scopolamine patches, glycopyrrolate, or other treatment regimens to manage oral secretions at the end of life?
Related Questions
When do you recommend starting a continuous opioid infusion for symptom control at the end of life?
Under what circumstances do you recommend POCUS guidance for lumbar puncture?
What do you think about using conventional thoracic imaging methods (e.g. X-ray, CT, etc.) to determine if a pleural effusion is of adequate size to consider thoracentesis?
At what point should you consider deactivating ICDs or implanted pacemakers in patients nearing the end of life but not imminently dying?
Does the experience level of the intubation operator affect outcomes related to pre-oxygenation with NIV versus an oxygen mask?
When do you consider ketamine to treat nonconvulsive status epilepticus?
What is your approach to treatment of patients with fulminant C difficile infection who required ileostomy creation or colectomy?
Is there a subset of patients in whom pre-oxygenation with NRB or BVM could be safely pursued?
What is your hemoglobin target for PRBC transfusion in cases of acute brain injury?
How do you identify which patients are at highest risk for decompensation and most likely to benefit from NIV for pre-oxygenation prior to intubation?
